Milestone® Pharmaceuticals to Present at the Upcoming BTIG Virtual Biotechnology Conference
Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) has announced its participation in the upcoming BTIG Virtual Biotechnology Conference, scheduled for August 5-6, 2024. The company's President and CEO, Joe Oliveto, will be featured in a Fireside Chat presentation on August 6th at 8 AM EDT.
Investors and interested parties can access the presentation live or as a replay for approximately 90 days after the event. The webcast will be available in the News & Events section of Milestone's corporate website at www.milestonepharma.com. This conference provides an opportunity for Milestone Pharmaceuticals to showcase its latest developments and engage with the investment community in the biotechnology sector.
Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) ha annunciato la sua partecipazione alla prossima Conferenza Virtuale di Biotecnologia BTIG, programmata per il 5-6 agosto 2024. Il Presidente e CEO dell'azienda, Joe Oliveto, sarà presente in una presentazione Fireside Chat il 6 agosto alle 8 AM EDT.
Investitori e parti interessate possono accedere alla presentazione in diretta o come replay per circa 90 giorni dopo l'evento. Il webcast sarà disponibile nella sezione News & Events del sito web aziendale di Milestone all'indirizzo www.milestonepharma.com. Questa conferenza offre un'opportunità a Milestone Pharmaceuticals di presentare i suoi ultimi sviluppi e interagire con la comunità degli investitori nel settore della biotecnologia.
Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) ha anunciado su participación en la próxima Conferencia Virtual de Biotecnología BTIG, programada para el 5-6 de agosto de 2024. El Presidente y CEO de la empresa, Joe Oliveto, participará en una presentación de Fireside Chat el 6 de agosto a las 8 AM EDT.
Los inversores y partes interesadas pueden acceder a la presentación en vivo o como una reproducción durante aproximadamente 90 días después del evento. La transmisión estará disponible en la sección de Noticias y Eventos del sitio web corporativo de Milestone en www.milestonepharma.com. Esta conferencia ofrece una oportunidad para que Milestone Pharmaceuticals muestre sus últimos desarrollos y se relacione con la comunidad inversora en el sector de biotecnología.
Milestone® Pharmaceuticals Inc. (Nasdaq: MIST)는 2024년 8월 5-6일 예정된 BTIG 가상 생명공학 회의에 참여한다고 발표했습니다. 회사의 회장 겸 CEO인 Joe Oliveto는 8월 6일 오전 8시 EDT에 Fireside Chat 발표에 참가할 예정입니다.
투자자 및 관심 있는 분들은 행사 후 약 90일 동안 생중계 또는 다시 보기를 할 수 있습니다. 웨비나는 Milestone의 기업 웹사이트의 뉴스 및 이벤트 섹션(www.milestonepharma.com)에서 제공됩니다. 이 회의는 Milestone Pharmaceuticals가 최신 개발 사항을 소개하고 생명공학 분야의 투자자 커뮤니티와 교류할 수 있는 기회를 제공합니다.
Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) a annoncé sa participation à la prochaine Conférence Virtuelle de Biotechnologie BTIG, prévue pour les 5 et 6 août 2024. Le président et PDG de l'entreprise, Joe Oliveto, participera à une présentation Fireside Chat le 6 août à 8h EDT.
Les investisseurs et toutes les parties intéressées peuvent accéder à la présentation en direct ou en replay pendant environ 90 jours après l'événement. Le webinaire sera disponible dans la section Actualités & Événements du site web de Milestone à l'adresse www.milestonepharma.com. Cette conférence offre à Milestone Pharmaceuticals l'opportunité de présenter ses derniers développements et d'interagir avec la communauté des investisseurs dans le secteur des biotechnologies.
Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) hat seine Teilnahme an der bevorstehenden BTIG Virtuellen Biotechnologiekonferenz bekannt gegeben, die für den 5.-6. August 2024 geplant ist. Der Präsident und CEO des Unternehmens, Joe Oliveto, wird am 6. August um 8 Uhr EDT in einer Fireside Chat-Präsentation auftreten.
Investoren und Interessierte können die Präsentation live oder als Wiederholung für etwa 90 Tage nach der Veranstaltung verfolgen. Das Webcast wird im Bereich News & Events der Unternehmenswebsite von Milestone unter www.milestonepharma.com verfügbar sein. Diese Konferenz bietet Milestone Pharmaceuticals die Möglichkeit, seine neuesten Entwicklungen vorzustellen und mit der Investoren-Community im Bereich Biotechnologie in Kontakt zu treten.
- None.
- None.
MONTREAL and CHARLOTTE, N.C., July 31, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that President and CEO, Joe Oliveto, will participate in the BTIG Virtual Biotechnology Conference, to take place from August 5-6, 2024.
The presentation will be in the form of a Fireside Chat to take place on August 6th at 8 AM EDT. The webcast will be available to watch both live and as a replay for approximately 90 days following the presentation in the News & Events section of Milestone's corporate website: www.milestonepharma.com.
About Milestone Pharmaceuticals
Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a biopharmaceutical company developing and commercializing innovative cardiovascular solutions to improve the lives of people living with complex and life-altering heart conditions. The Company’s focus on understanding unmet patient needs and improving the patient experience has led us to develop new treatment approaches that provide patients with an active role in self-managing their care. Milestone’s lead investigational product is etripamil, a novel calcium channel blocker nasal spray that is being studied for patients to self-administer without medical supervision to treat symptomatic episodic attacks associated with PSVT and AFib-RVR.
Contact:
Kim Fox, Vice President, Communications, kfox@milestonepharma.com
Investor Relations
Chris Calabrese, ccalabrese@lifesciadvisors.com
Kevin Gardner, kgardner@lifesciadvisors.com
FAQ
When is Milestone Pharmaceuticals (MIST) presenting at the BTIG Virtual Biotechnology Conference?
Who will be representing Milestone Pharmaceuticals (MIST) at the BTIG Virtual Biotechnology Conference?
How can investors access Milestone Pharmaceuticals' (MIST) presentation at the BTIG Virtual Biotechnology Conference?
What type of presentation will Milestone Pharmaceuticals (MIST) give at the BTIG Virtual Biotechnology Conference?
What are the dates for the BTIG Virtual Biotechnology Conference featuring Milestone Pharmaceuticals (MIST)?
